{"nctId":"NCT00926029","briefTitle":"Compare the Clinical Efficacy of Prototype Toothpastes","startDateStruct":{"date":"2008-01"},"conditions":["Dental Plaque"],"count":98,"armGroups":[{"label":"Fluoride control -A","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Fluoride"]},{"label":"Triclosan/Fluoride - B","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Triclosan, fluoride"]},{"label":"Triclosan/fluoride/metal salt- C","type":"EXPERIMENTAL","interventionNames":["Other: Metal salt"]}],"interventions":[{"name":"Fluoride","otherNames":["Colgate Winterfresh Gel"]},{"name":"Triclosan, fluoride","otherNames":["Colgate Total toothpaste"]},{"name":"Metal salt","otherNames":["New toothpaste formula being evaluated."]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Male or female volunteers 18-65 years of age.\n* Good general health.\n* Must sign informed consent form.\n* Minimum of 20 natural uncrowned teeth (excluding third molars) must be present.\n* No history of allergy to personal care consumer products, or their ingredients, relevant to any ingredient in the test products as determined by the dental/medical professional monitoring the study.\n\nExclusion Criteria:\n\n* Subject unable or unwilling to sign the informed consent form.\n* Medical condition which requires pre-medication prior to dental visits/procedures.\n* Moderate or advanced periodontal disease.\n* 5 or more decayed untreated dental sites at screening.\n* Other disease of the hard or soft oral tissues.\n* Impaired salivary function (e.g. Sjogren's syndrome or head and neck irradiation).\n* Use of medications that currently affect salivary flow.\n* Use of antibiotics or antimicrobial drugs within 30 days prior to study visit #1.\n* Pregnant or nursing women.\n* Participation in any other clinical study within 1 week prior to enrollment into this study.\n* Use of tobacco products.\n* Subjects who must receive dental treatment during the study dates.\n* Current use of Antibiotics for any purpose.\n* Presence of an orthodontic appliance.\n* History of allergy to common dentifrice ingredients.\n* History of allergy to zinc.\n* Immune compromised individuals (HIV, AIDS, immuno suppressive drug therapy).","healthyVolunteers":true,"sex":"ALL","minimumAge":"18 Years","maximumAge":"65 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Plaque Index","description":"Plaque Index score scale 0 to 5 (0 = no plaque, 1 = separate flecks of plaque on the tooth, 2 = a thin continuous band of plaque,3 = a band of plaque up to one-third of the tooth, 4 = plaque covering up to two thirds of the of the tooth, 5 = plaque covering two-thirds or more of the crown of the tooth)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.91","spread":"0.91"},{"groupId":"OG001","value":"0.84","spread":"0.25"},{"groupId":"OG002","value":"1.77","spread":"0.44"}]}]}]},{"type":"PRIMARY","title":"Gingivitis Index","description":"Gingivitis score- scale 0 to 3 (0 = no inflammation,1 = Mild inflammation-slight change in color and little change in texture 2 = Moderate inflammation-moderate glazing, redness, edema and hypertrophy. Tendency to bleed upon probing. 3 = Severe inflammation-marked redness and hypertrophy. Tendency to spontaneous bleeding)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.63","spread":"0.15"},{"groupId":"OG001","value":"0.51","spread":"0.17"},{"groupId":"OG002","value":"0.98","spread":"0.15"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":34},"commonTop":[]}}}